Amphastar Pharma (AMPH) Tops Q3 EPS by 5c

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $57.9 million versus the consensus estimate of $57.2 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Colony Bankcorp to acquire First Reliance in $163M stock-and-cash deal
• Jefferies Financial Group (JEF) Misses Q2 EPS by 22c